Science Explorer Back to mapMap
Discussion
Company · Gumi · South Korea

Wonbiogen (South Korea)

wonbiogen.co.krROR OpenAlex
Research works
2
fractional, all time
Citations
72
32.7 per fractional work
Top-10% rate
5.7%
all institutions 10.0%
Open access
24%
world 40%
International
38%
world 18%
Wonbiogen (South Korea)

Not ranked overall: Wonbiogen (South Korea) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Wonbiogen (South Korea) work in?

In all years, 55% of research at Wonbiogen (South Korea) is in Health Sciences, 32% in Life Sciences. Its largest fields are Medicine (55%), Biochemistry, Genetics and Molecular Biology (18%), Agricultural and Biological Sciences (9%).

Health Sciences: 1 fractional works · 54.5% of its workMedicine: 1 fractional works · 54.5% of its workLife Sciences: 1 fractional works · 31.8% of its workBiochemistry, Genetics and Molecular Biology: 0 fractional works · 18.2% of its workAgricultural and Biological Sciences: 0 fractional works · 9.1% of its workImmunology and Microbiology: 0 fractional works · 4.5% of its workPhysical Sciences: 0 fractional works · 13.6% of its workMaterials Science: 0 fractional works · 9.1% of its workEngineering: 0 fractional works · 4.5% of its workALL ITS WORKWonbiogen (SouthKorea)2fractional works, all years
Life Sciences32%Physical Sciences14%Health Sciences55%

Each ring splits the one inside it: the four domains of science, their fields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 3 domains and 6 fields, with their numbers
    1. Medicine154.5%
    1. Biochemistry, Genetics and Molecular Biology018.2%
    2. Agricultural and Biological Sciences09.1%
    3. Immunology and Microbiology04.5%
    1. Materials Science09.1%
    2. Engineering04.5%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

What are the most cited papers from Wonbiogen (South Korea)?

The most cited paper from Wonbiogen (South Korea) is "Preventing postoperative tissue adhesion using injectable carboxymethyl cellulose-pullulan hydrogels" (Sumi Bang, Young‐Gwang Ko, Won Il Kim et al., 2017), with 69 citations. Next come "Injectable pullulan hydrogel for the prevention of postoperative tissue adhesion" (65) and "Nanofiber mats composed of a chitosan-poly( d , l -lactic-co -glycolic acid)-poly(ethylene oxide) blend as a postoperative anti-adhesion agent" (28).

Most cited papers
#PaperReleasedCitations
1 Preventing postoperative tissue adhesion using injectable carboxymethyl cellulose-pullulan hydrogels Sumi Bang, Young‐Gwang Ko, Won Il Kim et al. · International Journal of Biological Macromolecules 17 Jul 2017 69
2 Injectable pullulan hydrogel for the prevention of postoperative tissue adhesion Sumi Bang, Eungjae Lee, Young‐Gwang Ko et al. · International Journal of Biological Macromolecules 13 Feb 2016 65
3 Nanofiber mats composed of a chitosan-poly( d , l -lactic-co -glycolic acid)-poly(ethylene oxide) blend as a postoperative anti-adhesion agent Jae Eok Ko, Young‐Gwang Ko, Won Il Kim et al. · Journal of Biomedical Materials Research Part B Applied Biomaterials 10 Jun 2016 28
4 Successive grafting of PHEMA and PIPAAm onto cell culture surface enables rapid cell sheet recovery Sun Jong Kim, Won Il Kim, Masayuki Yamato et al. · Tissue Engineering and Regenerative Medicine 24 May 2013 18
5 Attention-based Long Short Term Memory Model for DNA Damage Prediction in Mammalian Cells Mohammad Abdallah Alsharaiah, Laith H. Baniata, Omar Adwan et al. · International Journal of Advanced Computer Science and Applications Open access 2022 5
All 6 most cited papers, with filters and sorting

Which research topics does Wonbiogen (South Korea) publish most on?

By volume in 2022-now: Gut microbiota and health, Effects of Radiation Exposure, Reproductive tract infections research and Clostridium difficile and Clostridium perfringens research.

Gut microbiota and health0Gut microbiota and health: 0 fractional worksEffects of Radiation Exposure: 0 fractional worksReproductive tract infections research: 0 fractional worksClostridium difficile and Clostridium perfringens research: 0 fractional worksSperm and Testicular Function: 0 fractional works
Molecular BiologyRadiology, Nuclear Medicine and ImagingMicrobiologyInfectious Diseases1 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Gut microbiota and health Molecular Biology 0 works
  2. 2 Effects of Radiation Exposure Radiology, Nuclear Medicine and Imaging 0 works
  3. 3 Reproductive tract infections research Microbiology 0 works
  4. 4 Clostridium difficile and Clostridium perfringens research Infectious Diseases 0 works
  5. 5 Sperm and Testicular Function Reproductive Medicine 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available24.2%not open75.8%

World: 40% of research is openly available.

with international co-authors37.9%domestic only62.1%

World: 18% is written across borders.

How has Wonbiogen (South Korea)'s research output changed?

still counting201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Gumi

All research institutions in Gumi

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Wonbiogen (South Korea). Posts are plain text and can be reported.